Erratum: Meal size can be decreased in obese subjects through pharmacological acceleration of gastric emptying (The OBERYTH trial) (International Journal of Obesity (2011) 35 (829-837) DOI:10.1038/ijo.2010.210);Meal size can be decreased in obese subjects through pharmacological acceleration of gastric emptying (The OBERYTH trial)

International Journal of Obesity

Volumn 35, Issue 6, 2011, Pages 829-837

  Torra, S ^a   Ilzarbe, L ^a   Malagelada, J R ^b   Negre, M ^b   Mestre Fusco, A ^b   Aguade Bruix S ^b   Florensa, E ^b   Sue P ^b   Gras, B ^a   Hernandez, J J ^c   Casamitjana, R ^d   Garcia, M A ^a   Ros, F B ^a   Delgado Aros, S ^a  

^a HOSPITAL DEL MAR   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c Laboratori de Referencia de Catalunya   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

gastric emptying; meal sizex; satiation; stomach

Indexed keywords

CHOLECYSTOKININ; ERYTHROMYCIN; INSULIN;

ADULT; ARTICLE; CALORIC INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MALE; MEAL; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SATIETY; STOMACH EMPTYING; SYMPTOM; TREATMENT OUTCOME;

EID: 79958797588     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2010.248     Document Type: Erratum

References (41)

1. Kumanyika S, Jeffery RW, Morabia A, Ritenbaugh C, Antipatis VJ. Obesity prevention: the case for action. Int J Obes Relat Metab Disord 2002; 26: 425-436. (Pubitemid 34226170)
2. Woods SC. Gastrointestinal satiety signals I. An overview of gastrointestinal signals that influence food intake. Am J Physiol Gastrointest Liver Physiol 2004; 286: G7-G13. (Pubitemid 38055830)
3. Schwartz MW. Brain pathways controlling food intake and body weight. Exp Biol Med (Maywood) 2001; 226: 978-981.
4. Delgado-Aros S, Camilleri M, Castillo EJ, Cremonini F, Stephens D, Ferber I et al. Effect of gastric volume or emptying on meal-related symptoms after liquid nutrients in obesity: a pharmacologic study. Clin Gastroenterol Hepatol 2005; 3: 997-1006. (Pubitemid 41415748)
5. Marmonier C, Chapelot D, Louis-Sylvestre J. Effects of macronutrient content and energy density of snacks consumed in a satiety state on the onset of the next meal. Appetite 2000; 34: 161-168.
6. Delgado-Aros S, Kim DY, Burton DD, Thomforde GM, Stephens D, Brinkmann BH et al. Effect of GLP-1 on gastric volume, emptying, maximumvolume ingested, and postprandial symptoms in humans. Am J Physiol Gastrointest Liver Physiol 2002; 282: 424-431.
7. Geliebter A, Hashim SA. Gastric capacity in normal, obese, and bulimic women. Physiol Behav 2001; 74: 743-746. (Pubitemid 34076623)
8. Delgado-Aros S, Cremonini F, Castillo JE, Chial HJ, Burton DD, Ferber I et al. Independent influences of body mass and gastric volumes on satiation in humans. Gastroenterology 2004; 126: 432-440. (Pubitemid 38182300)
9. Garner DM, Garfinkel PE. The Eating Attitudes Test: an index of the symptoms of anorexia nervosa. Psychol Med 1979; 9: 273-279. (Pubitemid 9198794)
10. Garner DM, Olmsted MP, Bohr Y, Garfinkel PE. The eating attitudes test: psychometric features and clinical correlates. Psychol Med 1982; 12: 871-878. (Pubitemid 13174854)
11. Mintz LB, O'Halloran MS. The Eating Attitudes Test: validation with DSM-IV eating disorder criteria. J Pers Assess 2000; 74: 489-503. (Pubitemid 30429104)
12. Geliebter A, Hassid G, Hashim SA. Test meal intake in obese binge eaters in relation to mood and gender. Int J Eat Disord 2001; 29: 488-494. (Pubitemid 32295641)
13. Geliebter A, Melton PM, McCray RS, Gallagher DR, Gage D, Hashim SA. Gastric capacity, gastric emptying, and test-meal intake in normal and bulimic women. Am J Clin Nutr 1992; 56: 656-661.
14. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370. (Pubitemid 13098606)
15. Johnston M, Pollard B, Hennessey P. Construct validation of the hospital anxiety and depression scale with clinical populations. J Psychosom Res 2000; 48: 579-584.
16. Delgado-Aros S, Chial HJ, Burton DD, McKinzie S, Ferber I, Camilleri C. Reliability of the nutrient drink test to assess maximum volume intake and postprandial symptoms. Gastroenterology 2002; 122(4 Suppl 1): A-550.
17. Deutsch JA. The role of the stomach in eating. Am J Clin Nutr 1985; 42(5 Suppl): 1040-1043. (Pubitemid 16148057)
18. Deutsch JA, Jang Ahn S. The splanchnic nerve and food intake regulation. Behav Neural Biol 1986; 45: 43-47. (Pubitemid 16162293)
19. Deutsch JA, Young WG, Kalogeris TJ. The stomach signals satiety. Science 1978; 201: 165-167. (Pubitemid 8401982)
20. Schwartz GJ, McHugh PR, Moran TH. Gastric loads and cholecystokinin synergistically stimulate rat gastric vagal afferents. Am J Physiol 1993; 265(4 Part 2): 872-876.
21. Schwartz GJ, Moran TH, White WO, Ladenheim EE. Relationships between gastric motility and gastric vagal afferent responses to CCK and GRP in rats differ. Am J Physiol 1997; 272(6 Part 2): 1726-1733.
22. Safieh-Garabedian B, Poole S, Allchorne A, Winter J, Woolf CJ. Contribution of interleukin-1 beta to the inflammationinduced increase in nerve growth factor levels and inflammatory hyperalgesia. British Journal of Pharmacology 1995; 115: 1265-1275.
23. Delgado-Aros S, Camilleri M, Cremonini F, Ferber I, Stephens D, Burton DD. Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia. Gastroenterology 2004; 127: 1685-1694. (Pubitemid 39575847)
24. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002; 418: 650-654.
25. Yuzuriha H, Inui A, Goto K, Asakawa A, Fujimiya M, Kasuga M. Intracerebroventricular administration of NPY stimulates resistin gene expression in mice. Int J Mol Med 2003; 11: 675-676.
26. Smith GP, Jerome C, Norgren R. Afferent axons in abdominal vagus mediate satiety effect of cholecystokinin in rats. Am J Physiol 1985; 249(5 Part 2): R638-R641. (Pubitemid 16204020)
27. Wu XY, Zhu JX, Gao J, Owyang C, Li Y. Neurochemical phenotype of vagal afferent neurons activated to express C-FOS in response to luminal stimulation in the rat. Neuroscience 2005; 130: 757-767. (Pubitemid 39601447)
28. Reidelberger RD, Hernandez J, Fritzsch B, Hulce M. Abdominal vagal mediation of the satiety effects of CCK in rats. Am J Physiol Regul Integr Comp Physiol 2004; 286: R1005-R1012. (Pubitemid 38661387)
29. Koda S, Date Y, Murakami N, Shimbara T, Hanada T, Toshinai K et al. The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats. Endocrinology 2005; 146: 2369-2375. (Pubitemid 40577525)
30. Abbott CR, Monteiro M, Small CJ, Sajedi A, Smith KL, Parkinson JR et al. The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res 2005; 1044: 127-131. (Pubitemid 40616060)
31. Gibbs J, Young RC, Smith GP. Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol 1973; 84: 488-495.
32. West DB, Fey D, Woods SC. Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats. Am J Physiol 1984; 246(5 Part 2): R776-R787. (Pubitemid 14111438)
33. Schwartz GJ, McHugh PR, Moran TH. Pharmacological dissociation of responses to CCK and gastric loads in rat mechanosensitive vagal afferents. Am J Physiol 1994; 267(1 Part 2): R303-R308.
34. Baskin DG, Wilcox BJ, Figlewicz DP, Dorsa DM. Insulin and insulin-like growth factors in the CNS. Trends Neurosci 1988; 11: 107-111. (Pubitemid 18053669)
35. Woods SC, Lotter EC, McKay LD, Porte Jr D. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 1979; 282: 503-505. (Pubitemid 10126541)
36. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993; 42: 1663-1672. (Pubitemid 23318125)
37. Figlewicz DP, Stein LJ, West D, Porte Jr D, Woods SC. Intracisternal insulin alters sensitivity to CCK-induced meal suppression in baboons. Am J Physiol 1986; 250(5 Part 2): R856-R860.
38. Feinle C, D'Amato M, Read NW. Cholecystokinin-A receptors modulate gastric sensory and motor responses to gastric distension and duodenal lipid. Gastroenterology 1996; 110: 1379-1385. (Pubitemid 26134068)
39. Feinle C, Grundy D, Otto B, Fried M. Relationship between increasing duodenal lipid doses, gastric perception, and plasma hormone levels in humans 1. Am J Physiol Regul Integr Comp Physiol 2000; 278: R1217-R1223. (Pubitemid 30366450)
40. Asakawa A, Inui A, Yuzuriha H, Ueno N, Katsuura G, Fujimiya M et al. Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology 2003; 124: 1325-1336. (Pubitemid 36531807)
41. Batterham RL, Le Roux CW, Cohen MA, Park AJ, Ellis SM, Patterson M et al. Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab 2003; 88: 3989-3992. (Pubitemid 37034556)